BioFlorida Conference Recognizes Statewide Growth and Leadership

  BioFlorida Conference Recognizes Statewide Growth and Leadership

  Dr. Phillip Frost and OPKO Health, Inc. Honored for Industry Contributions

BioFlorida Conference 2013

Business Wire

TAMPA, Fla. -- September 24, 2013

Nearly 500 business executives, scientists and other stakeholders gathered in
Tampa last week for the 16^th BioFlorida Conference, the hallmark industry
event for Florida’s life sciences industry. This year’s event was stacked with
dynamic speakers and panelists representing all sectors of the life sciences
industry including biotechnology, pharmaceuticals, medical devices and
bioagriculture.

Throughout the Conference, individuals and organizations that have made
significant contributions to the life sciences industry were recognized and
applauded for their impact on this industry which is of growing importance to
Florida’s economy.

BioFlorida Lifetime Achievement Award

The inaugural BioFlorida Lifetime Achievement Award was presented to Phillip
Frost, MD, CEO and Chairman of OPKO Health, Inc., and Chairman of the Board of
Directors of Teva Pharmaceutical Industries, Ltd. Dr. Frost, a Floridian, was
recognized as one of the country’s most prominent biotechnology executives and
a visionary in the life sciences field whose career success has contributed to
economic growth in Florida and the improvement of patient lives.

Accepting the award on behalf of Dr. Frost, Steve Rubin, Executive Vice
President and Director of OPKO Health, Inc. thanked BioFlorida for the
recognition while noting that Dr. Frost wanted to also convey that his career
is far from over. “With many career milestones, OPKO being the latest and
perhaps his best, he is still very much engaged in the industry and is certain
there is more to come,” said Rubin.

During Dr. Frost’s notable career, he has successfully founded several
pharmaceutical companies and has overseen the development and
commercialization of a multitude of pharmaceutical products. Prior to OPKO,
Dr. Frost served as Chairman of the Board and CEO of IVAX Corporation until
the sale of IVAX to Teva, and as Chairman of the Board of Key Pharmaceuticals
until its acquisition by Schering Plough. While helping people live healthier
lives through medications, charity is also a focus for Dr. Frost. He serves as
a board member and advisor to a variety of health, educational and community
institutions including the Smithsonian Institution, the University of Miami
and the Mount Sinai Medical Center.

David J. Gury Company of the Year

The David J. Gury Company of the Year award honors a company that has had
significant achievements leading to the advancement of the life sciences in
Florida. This year’s award recipient was OPKO Health, Inc.

OPKO is a multi-national pharmaceutical and diagnostics company headquartered
in Miami. The company aims to establish industry-leading positions in large
and rapidly growing medical markets by leveraging discovery, development, and
commercialization expertise and novel and proprietary technologies. Led by Dr.
Phillip Frost, OPKO is heralded as one of Florida’s premier biotechnology
companies. OPKO has had an outstanding year with revenues more than doubling
in the second quarter and nearly tripling in the first half of 2013. Within
the last month, OPKO announced it completed the acquisition of PROLOR Biotech
and listed on the Tel Aviv stock exchange. With the inclusion of PROLOR's
pipeline, OPKO now has four significant products in Phase III clinical
development and a robust pipeline of important therapeutic and unique
diagnostic products in various stages of development.

Weaver H. Gaines Entrepreneur Award

James D. Talton, PhD, President and Chief Executive Officer of
Nanotherapeutics, was honored with the Weaver H. Gaines Entrepreneur Award,
which recognizes an entrepreneur who has made extraordinary contributions to
the growth of the life sciences in the leadership of a company or institution.
Nanotherapeutics, a University of Florida (UF) Sid Martin Biotechnology
Incubator graduate located in Alachua, FL, is a privately-held emerging
biopharmaceutical company with both proprietary platform technologies and a
diversified pipeline of products.

Under Dr. Talton’s leadership, Nanotherapeutics was awarded a contract by the
Department of Defense (DOD) for the research and development services in
support of medical countermeasure capabilities. These capabilities established
by Nanotherapeutics will allow the DOD to more efficiently and expeditiously
develop Medical Countermeasures (MCM) to protect and treat military
populations against chemical, biological, radiological, and nuclear (CBRN)
attacks and outbreaks of naturally occurring emerging and genetically
engineered infectious diseases. Through private financing, Nanotherapeutics
will build its 165,000 square foot Advanced Development and Manufacturing
Center in Alachua that will result in 150 new jobs.

BioFlorida Leadership Award

The BioFlorida Leadership Award was presented to Patti Breedlove, Director of
the UF Sid Martin Biotechnology Incubator, an organization fostering the
development of new commercial ventures related to UF research in all areas
broadly relating to the molecular life sciences including medicine,
agriculture, and the chemical and environmental sciences. Ms. Breedlove was
recognized for her leadership role within BioFlorida, dedicating significant
time to the organization’s mission and has acted as a true ambassador to fuel
the growth of life sciences in Florida.

Ms. Breedlove is an active participant on the BioFlorida executive team and
board of directors, while heralding the benefits of membership as chair of the
membership committee. She also leads the Celebration of Biotechnology, an
annual event in Alachua to recognize biotechnology advances. Under her
leadership in July 2013, the Sid Martin Biotechnology Incubator was ranked
“World’s Best University Biotechnology Incubator,” according to an
international study conducted by the Sweden-based research group UBI. The
inaugural benchmarking report was based on an extensive analysis of 150
incubators in 22 countries.

Legislator of the Year Award

Representative Matt Hudson, Chair of the Health Care Appropriations
Subcommittee, was awarded the Legislator of the Year Award for his commitment
to advancing research and development in the industry.

Upon being elected to the Florida House, Representative Hudson immediately
understood the importance of supporting the life sciences industry. During the
2013 legislative session, Representative Hudson sponsored and supported the
passage of HB365, legislation related to biosimilars that ensures a pathway
for safe substitution of biosimilar medicines. Additionally, he advocated for
and secured increased funding of biomedical and cancer research.

Another highlight of the Conference was the release of the BioFlorida and
Pharmaceutical Research and Manufacturers of America (PhRMA) report “Research
in Your Backyard: Pharmaceutical Clinical Trials in Florida.” Working in
collaboration with Florida clinicians and research institutions, the report
shows America’s biopharmaceutical research companies have conducted more than
7,800 clinical trials of new medicines in Florida over the last 14 years and
have supported 84,000 Florida jobs. These trials have benefited thousands of
Florida patients, the state’s economy and the advancement of science and
patient care.

Florida’s life sciences industry has a full calendar of events for the
remainder of 2013. Additional upcoming events hosted by BioFlorida can be
found here.

About BioFlorida

BioFlorida (BioFlorida.com) is the voice of Florida’s life sciences industry,
representing more than 3,000 companies and research organizations in the
biotechnology, pharmaceuticals, medical devices and bioagriculture fields that
employ nearly 84,000 Floridians. BioFlorida’s member-driven initiatives
provide a strong business climate for development and production of innovative
technologies and products that improve lives and promote economic benefits to
the state.

Contact:

Moore Communications Group
Jamie Fortune, 850-224-0174
jamief@moorecommgroup.com
 
Press spacebar to pause and continue. Press esc to stop.